| Project/Area Number |
02671014
|
|---|
| Research Category |
Grant-in-Aid for General Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | Tokyo College of Pharmacy |
|---|
Principal Investigator |
MORI Yo Ph.D. Tokyo College of Pharmacy Professor Dept. of Biochemistry, 薬学部, 教授 (50057303)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
HONDA Atsushi Ph.D. Tokyo College of Pharmacy Assistant Prof.Dept. of Biochemistry, 薬学部, 講師 (70112886)
|
|---|
| Project Period (FY) |
1990 – 1992
|
| Project Status |
Completed (Fiscal Year 1992)
|
| Budget Amount *help |
¥2,200,000 (Direct Cost: ¥2,200,000)
Fiscal Year 1992: ¥400,000 (Direct Cost: ¥400,000)
Fiscal Year 1991: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1990: ¥1,300,000 (Direct Cost: ¥1,300,000)
|
|---|
| Keywords | Hyaluronic acid synthesis / Epidermal growth factor (EGF) / Insulin-like growth factor-l (IGF-I) / Genistein / Prostaglandin E2 / Cyclic AMP / Signal transduction pathways / Rabbit pericardial cells / IL-1 / プロスタグランジンE_2(PGE_2) / 心膜炎 / ウサギ心膜 / 細胞内情報伝達系 / 心膜細胞 / 上皮成長因子(EGF) / インシュリン様成長因子ーI(IGFーI) / チロシンキナ-ゼ阻害剤 |
|---|
| Research Abstract |
We studied the effects of growth factors (IGF-I and/or EGF) or prostaglandin E_2 (PGE_2) on hyaluronic acid (HA) synthesis in rabbit pericardial mesothelial cells, and the following results were obtained.
1. Stimulation of HA synthesis by IGF-I and/or EGF
(1) Combined exposure of pericardial cells to IGF-I and EGF cooperatively increased HA synthesis and the level of hyaluronic aid synthase (HASase) activity over that seen with or without IGF-I or EGF alone, but did not significantly stimulate the sulfated glycosaminoglycan synthesis. (2) Increase in the level of HA synthesis and HASase activity induced by these growth factors was blocked after pretreatment with a tyrosine-specific protein kinase inhibitor, genistein. (3)Genistein had no direct inhibitory effect on HASase activity. These results suggest that cooperative enhancement of HA synthesis induced by combined use of IGF-I and EGF could be mediated by a receptor tyrosine kinase-involved transmembrane signaling process that is resp
… More
onsive to IGF-I and EGF.
2. Stimulation of HA synthesis by PGE_2 (1) PGE_2 (10-1000 ng/ml) stimulated HA synthesis and the level of HASase activity in a dose- and time-dependent manner, but PGF_2alpha didn't. (2) Cyclic AMP (cAMP) levels in the cells peaked (about a 7-fold increase) at 5-10 min after adding PGE_2 (1000 ng/ml). (3) Increased HA synthesis induced by PGE_2 was significantly inhibited after pretreatment with either an adenylate cyclase inhibitor (2', 5'-dideoxyadenosine) or a cAMP-dependent protein kinase (PK) inhibitor (PKI 5-24), but there was no inhibition with the PKC inhibitor (H-7). (4) When the intracellular cAMP level was raised by manipulating levels of dibutyryl cyclic AMP (Bt_2-cAMP) or forskolin, HA synthesis and the level of HASase activity were also stimulated. These results suggest that PGF_2 produced by cells stimulates HA synthesis in rabbit pericardial cells and that the stimulation mechanism involves in the cAMP-mediated protein kinase signal transduction process. Less
|
